Stocksigma LogoStocksigma Logo

Ishita Drugs & Industries Ltd - Financial Result for the Quarter ended 30th Sep'26 (Standalone, INR Lakh)

■ Revenue: 303 (-1.1% YoY | -3.6% QoQ) ■ EBITDA: 16.3 (-12.3% YoY | -48.9% QoQ) ■ EBITDA Margin (%): 5.4 (-69 bps YoY | -476 bps QoQ) ■ PAT: 16.1 (+12.2%

Ishita Drugs & Industries Ltd - Financial Result for the Quarter ended 30th Sep'26 (Standalone, INR Lakh)

Ishita Drugs & Industries Ltd · Outcome · 03 Nov 2026, 10:50 pm

Ishita Drugs & Industries Ltd - Financial Result for the Quarter ended 30th Sep'26 (Standalone, INR Lakh) ■ Revenue: 303 (-1.1% YoY | -3.6% QoQ) ■ EBITDA: 16.3 (-12.3% YoY | -48.9% QoQ) ■ EBITDA Margin (%): 5.4 (-69 bps YoY | -476 bps QoQ) ■ PAT: 16.1 (+12.2% YoY | -30.1% QoQ) ■ EPS (INR): 0.54 (+12.5% YoY | -29.9% QoQ)

Original exchange filing (PDF)

More announcements from Ishita Drugs & Industries Ltd

All Ishita Drugs & Industries Ltd announcements